| ESVC – European Society of Veterinary Cardiology |
| ESVC-P-1 |
Patata |
Normalized left atrial diameter in healthy and cardiomyopathic cats |
| ESVC-P-2 |
Alibrandi |
Evaluation of the "Eko DUO" device in dogs and cats: a new smartphone-based digital stethoscope paired with phonocardiography and electrocardiography |
| ESVC-P-3 |
Reis-Ferreira |
MiR-146a may be a new biomarker of left ventricle remodeling in dogs with myxomatous mitral valve disease |
| ESVC-P-4 |
Matos |
Assessment of pulmonary hypertension in dogs with heartworm by using the ratio between the right and left ventricle |
| ESVC-P-5 |
Marchesotti |
A modified subcostal echocardiographic view to assess patent ductus arteriosus size in dogs |
| ESVC-P-6 |
Galizzi |
Aldosterone-progesterone relationship in sexually intact Chihuahua bitches |
| ESVC-P-7 |
Peters |
Cardiac troponin I as a prognostic marker for dogs admitted to the emergency service. |
| ESVC-P-8 |
Bini |
Echocardiographic variables predicting patent ductus arteriosus minimal ductal diameter and ampulla dimension in dogs |
| ESVC-P-9 |
Foulex |
hypertrophic cardiomyopathy is not the sole echocardiographic phenotype associated with feline hyperthyroidism: a retrospective study on 107 cats (2005-2020). |
| ESVC-P-10 |
Schreiber |
Ventricular pre-excitation in cats: 17 cases |
| ESVC-P-11 |
Batista |
Echocardiographic changes in puppies of dogs under 10 kg |
| ESVC-P-12 |
Domanjko Petrič |
Effects of coenzyme Q10 supplementation on oxidative stress markers, inflammatory markers, lymphocyte subpopulations, and clinical status in dogs with myxomatous mitral valve disease |
| ESVC-P-13 |
Costa-Rodríguez |
Elevations in serum cortisol in dogs with heartworm disease as a biomarker of stress |
| ESVC-P-14 |
Batista |
Effects of levomepromazine on electrocardiographic features in propofol and isoflurane-anesthetized dogs |
| ESVC-P-15 |
Romito |
Prognostic role of clinical and echocardiographic factors in dogs with atrial fibrillation secondary to myxomatous mitral valve disease and dilated cardiomyopathy |
| ESVC-P-16 |
Matos |
Usefulness of tissue doppler imaging in the evaluation of pulmonary hypertension in dogs with heartworm |
| SCH – Society of Comparative Hepatology |
| SCH-P-1 |
Martinez |
Investigation of the role of bacteria in canine neutrophilic cholangitis using fluorescence in situ hybridisation |
| SCH-P-2 |
Habermaass |
Serum amino acids in canine chronic hepatitis: results in 16 dogs |
| ESVCP – European Society of Veterinary Clinical Pathology |
| ESVCP-P-1 |
Acke |
Classification of pleural effusion in 25 cats based on simplified Light’s criteria with assessment of fluid point-of-care N-terminal pro B-type natriuretic peptide as a marker of congestive heart failure and fluid amylase as a marker of neoplasia |
| ESVNU – European Society of Veterinary Nephrology and Urology |
| ESVNU-P-1 |
Zambarbieri |
Renal hyperparathyroidism and survival in dogs affected by chronic kidney disease |
| ESVNU-P-2 |
Biourge |
Prospective testing of a model to predict development of chronic kidney disease in aged cats attending routine veterinarian consultations. |
| ESVNU-P-3 |
Pulido Vega |
Evaluation of preoperative ultrasonographic parameters associated with long-term renal recovery after treatment of feline unilateral ureteral obstruction |
| ESVNU-P-4 |
Marynissen |
Comparison of liquid chromatography-tandem mass spectrometry method and enzyme linked immunosorbent assay for serum symmetric dimethylarginine in elderly dogs |
| ESVNU-P-6 |
Kaufmann |
Presentation, diagnosis, mineral findings and management of ureteral calculi in dogs: 14 cases (2010 – 2021) |
| ESVNU-P-7 |
Nicolaysen |
A prospective study of kidney injury following Vipera berus envenomation in dogs sampled over a 5-month period |
| ESVNU-P-8 |
Öman |
Canine pyometra and urinary tract infection |
| ESCG – European Society of Comparative Gastroenterology |
| ESCG-P-1 |
Barko |
Altered Tryptophan Metabolism in Cats with Chronic Inflammatory Enteropathy or Alimentary Small Cell Lymphoma |
| ESCG-P-2 |
Hanifeh |
Gastric mucosal and plasma matrix metalloproteinase-9 activities in dogs with gastric mucous dysplasia and carcinoma |
| ESCG-P-3 |
Sabetti |
Description and treatment of non-neoplastic duodenal bulb ulcer in twelve dogs: an observational study |
| ESCG-P-4 |
Trewin |
Pre-illness dietary risk factors in dogs with chronic enteropathy |
| ESCG-P-5 |
Ferriani |
Fecal microbiota analysis in cats with inflammatory bowel disease or small cell lymphoma before and after therapy: a prospective comparison study |
| ESCG-P-6 |
Leal |
The role of hydrolysed diet in the management of chronic diarrhoea in dogs – is it always the first therapeutic step?- A retrospective multicentric study |
| ESCG-P-7 |
Cristóbal Verdejo |
Study of oxidative stress biomarkers in dogs with chronic inflammatory enteropathy |
| ESCG-P-8 |
Bandara |
Feline chronic inflammatory enteropathy: evaluation of treatment outcome and survival in 80 cases |
| ISCAID – International Society for Companion Animal Infectious Diseases |
| ISCAID-P-2 |
Breu |
Immune responses of 4321 European dogs to Borrelia antigens (2019-2021) |
| ISCAID-P-3 |
Jaffey |
Evaluation of serum 25-hydroxyvitamin D, c-reactive protein, and haptoglobin as biomarkers in dogs with histoplasmosis |
| ISCAID-P-4 |
Rodriguez-Sanz |
Evolution over a 20-year period of the predisposing factors and clinical outcomes of dogs with leishmaniosis: Are hosts getting weaker or parasites stronger? |
| ISCAID-P-5 |
Schäfer |
Molecular and serological detection of Anaplasma phagocytophilum in dogs from Germany (2008-2020) |
| ISCAID-P-6 |
Rodriguez-Cobos |
Aelurostrongylus abstrusus prevalence in cats from Spain |
| ISCAID-P-7 |
Dias |
Prognostic factors for in-hospital mortality in dogs with clinical leishmaniosis - a retrospective study |
| ISCAID-P-8 |
Roels |
Biomolecular investigation for Capillaria spp. infections on bronchoalveolar lavage fluid of owned domestic dogs presented for chronic cough in Belgium |
| ISCAID-P-9 |
Rösch |
Primary and secondary aspergillosis in dogs |
| ESVIM – European Society of Veterinary Internal Medicine |
| ESVIM-P-1 |
Johnson |
Utility of historical findings, cytologic assessment, and microbial culture in determining the etiology of pyothorax in 29 cats and 60 dogs (2010-2020) |
| ESVIM-P-2 |
Clercx |
Investigation of serum circulating cell free nucleosomes as biomarker of canine idiopathic pulmonary fibrosis in West Highland white terriers |
| ESVIM-P-3 |
Chang |
A retrospective evaluation of efficacy and tolerability of buprenorphine as an antitussive agent |
| ESVIM-P-4 |
Dorn |
Calculation of a reference interval for normal rectal temperature in dogs using an algorithm for mixed data. |
| ESVIM-P-5 |
Rosu |
Comparison of mycophenolate mofetil and cyclosporine A in dogs with primary immune-mediated hemolytic anemia in terms of therapeutic response, side effects and outcome |
| ESVIM-P-6 |
Mischke |
Pharmacokinetics of a single orally administered immunosuppressive dosage of cyclosporine A in healthy cats |
| ESVIM-P-7 |
Theron |
Laryngeal silicone stent as a treatment option for laryngeal paralysis in dogs: A case series of 8 dogs (2020-2022) |
| ESVIM-P-8 |
Mischke |
Cyclosporin A blood levels and dose adjustment in dogs with primary immune-mediated haemolytic anaemia |
| ESVIM-P-9 |
Bogedale |
Obtaining reference values of rectal temperature in adult cats using an algorithm for mixed data |
| ESVIM-P-10 |
Hukkinen |
Degenerative condition in lower airway cartilage as predisposing factor for recurrent bacterial bronchopneumonia in Irish Wolfhounds |
| ESVIM-P-11 |
Garcia Liotard |
Are clinical signs predictive of the aetiology of chronic nasal diseases in dogs? |
| ESVONC – European Society of Veterinary Oncology |
| ESVONC-P-1 |
Lyseight |
Metronomic chlorambucil as treatment for canine solid tumours |
| ESVONC-P-2 |
Lajoinie |
Electrochemotherapy with carboplatin for the treatment of feline squamous cell carcinoma: a pilot study regarding safety and effectiveness. |
| ESVE – European Society of Veterinary Endocrinology |
| ESVE-P-1 |
Bacon |
Evaluation of the accuracy of an alternative cortisol immunoassay as a screening test for canine hypoadrenocorticism. |
| ESVE-P-2 |
Lecot |
Serum Amyloid A concentration at diagnosis as a predictor of clinical remission in cats with diabetes mellitus: a retrospective study of 53 cases |
| ESVE-P-3 |
Schäfer |
Tailored reference intervals for urinary corticoid:creatinine ratio in dogs based to the outcome of the low-dose dexamethasone suppression test |
| ESVE-P-4 |
Blunschi |
Development and validation of a questionnaire to assess health-related quality-of-life in cats with hyperthyroidism |
| ESVE-P-5 |
Csöndes |
mRNA expression of canine glucocorticoid receptor α and P splice variants in peripheral blood samples of dogs with Cushing’s syndrome |
| ESVE-P-6 |
Watson |
Evaluating feline plasma steroid profiles using liquid chromatography tandem mass spectrometry |
| ESVE-P-7 |
Fabrès |
Clinical features of primary hyperaldosteronism in 127 cats: a multicentre retrospective review |
| ESVE-P-8 |
Güssow |
Validation and establishment of reference intervals of a chemiluminescent assay for the measurement of insulin-like growth factor-1 in cats |
| ESVE-P-9 |
Golinelli |
Dopamine and somatostatin receptors and filamin A expression in normal pituitaries and corticotroph adenomas in dogs |
| ESVE-P-10 |
van Bokhorst |
Laparoscopic versus open adrenalectomy in 70 dogs with functional or hormonally silent adrenal tumors |
| ESVE-P-11 |
Miceli |
Trilostane treatment for feline hypercortisolism: Latin America multicenter study, 43 cases (2012-2022) |
| ESVCN – European Society of Veterinary Comparative Nutrition |
| ESVCN-P-1 |
Leal |
The perception of Portuguese pet owners about veterinary approach to nutrition and weight management in companion animals |
| ESVCN-P-2 |
Cavalieri Carciofi |
Different starch to protein ratios in kibble diets fed ad libitum on body weight control, body composition, water turnover and physical activity in neutered cats living in homes |
